Rennova Health, Inc.
RNVAW
Other OTC0.01
USD
+0.00
- -
CIK
0000931059
Return %
Stock
S&P500
1Y
- -
26.84
3Y
- -
77.03
5Y
- -
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Seamus Lagan
- Full Time Employees
- 63
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 931 Village Boulevard West Palm Beach FL United States of America
- IPO Date
- Nov 3, 2015
- CIK
- 0000931059
- Website
- rennovahealth.com
- Similar Companies
- Business
- Rennova Health, Inc. (OTC: RNVA) provides healthcare services focused on rural communities, operating Big South Fork Medical Center, a critical access hospital in Oneida, Tennessee; planning to reopen a hospital and physicians practice in Jamestown, Tennessee; and managing a rural clinic in Kentucky. The company delivers innovation-driven solutions including diagnostic laboratory testing, revenue cycle management, electronic health records, lab ordering and reporting software, medical billing, and behavioral health services through subsidiaries such as Myrtle Recovery Centers; it also holds a strategic investment in InnovaQor, Inc. (OTC: INQR). Founded in 1989 and headquartered in West Palm Beach, Florida, Rennova targets healthcare providers, patients, and individuals in the United States with emphasis on underserved regions. In June 2024, Rennova completed a stock exchange agreement transferring its Myrtle Recovery Centers behavioral health subsidiary to FOXO Technologies, Inc. (NYSE American: FOXO) for $500,000 in FOXO common stock; it also entered an agreement to exchange its Rennova Community Health, Inc. subsidiary, primarily comprising Big South Fork Medical Center, for $20 million in FOXO convertible preferred stock, with closing expected in Q3 2024 subject to shareholder approval. These transactions enhance capital access for growth, position Rennova as FOXO's potential controlling shareholder, and enable monetization of FOXO holdings, while FOXO anticipates over $20 million in annual revenue from the acquired operations.